Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|October 5, 2011
Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumoniaChristopher M Rubino, Sujata M Bhavnani, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult SubjectsChristopher M Rubino, Sujata M Bhavnani, Jeffery S Loutit, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2014
Population pharmacokinetic analyses for BC-3781 using phase 2 data from patients with acute bacterial skin and skin structure infectionsC M Rubino, B Xue, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrataJustin C Bader, Elizabeth A Lakota, Shawn Flanagan, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh modelSharath S Hegde, Olanrewaju O Okusanya, Robert Skinner, et al.
Open Forum Infectious Diseases|July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming PatientsPaul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2016
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection ModelBrian D VanScoy, Michael Trang, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Pharmacokinetic-Pharmacodynamic Evaluation of Ertapenem for Patients with Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaJ C Bader, E A Lakota, G E Dale, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhiBrent M Booker, Patrick F Smith, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection ModelBrian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.
Pageof 16